Key result
HDL mimetics show anti-inflammatory promise by binding oxidized lipids and promoting cholesterol efflux.
Reveals diverse peptide and lipid configurations of HDL mimetics, highlighting their cholesterol clearance and anti-inflammatory properties for therapy.
HDL mimetics have been constructed from a number of peptides and proteins with varying structures, all of which bind lipids found in HDL. HDL mimetics containing a peptide or protein have been constructed with as few as 4 and as many as 243 amino acid residues. Some HDL mimetics have been constructed with lipid but without a peptide or protein component. Some HDL mimetics promote cholesterol efflux, some have been shown to have a remarkable ability to bind oxidized lipids compared to human apolipoprotein A-I (apoA-I). Many of these peptides have been shown to have antiinflammatory properties. Based on studies in a number of animal models and in early human clinical trials, HDL mimetics appear to have promise as diagnostic and therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Navab et al. (2009) reported a review. HDL mimetics vs. human apolipoprotein A-I (apoA-I) was evaluated. HDL mimetics composed of 4 to 243 amino acid residues bind oxidized lipids, promote cholesterol efflux, and show antiinflammatory promise in early clinical trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: